TCW Group Inc Acquires Accuray Inc Shares for Strategic Expansion

TCW Group Inc acquired 11.9 million shares of Accuray Inc at $1.29 per share, expanding its portfolio in the medical devices sector. Accuray Inc specializes in radiation oncology and has a market capitalization of $126.7 million. TCW Group's investment in Accuray Inc reflects its strategy of seeking long-term value in companies facing short-term challenges. Accuray Inc's financial health is moderate, with a moderate financial strength rank and low profitability and growth ranks. The company has experienced a year-to-date price decline of 36.92% and a significant drop of 94.14% since its IPO.